Synchronized and controlled release of metformin hydrochloride/glipizide from elementary osmotic delivery.

about

Synchronized and controlled release of metformin hydrochloride/glipizide from elementary osmotic delivery.

Item

http://www.wikidata.org/entity/Q39699017

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年学术文章

@wuu

2016年学术文章

@zh-cn

2016年学术文章

@zh-hans

2016年学术文章

@zh-my

2016年学术文章

@zh-sg

2016年學術文章

@yue

2016年學術文章

@zh

2016年學術文章

@zh-hant

name

Synchronized and controlled re ...... m elementary osmotic delivery.

@en

Synchronized and controlled re ...... m elementary osmotic delivery.

@nl

type

Item

label

Synchronized and controlled re ...... m elementary osmotic delivery.

@en

Synchronized and controlled re ...... m elementary osmotic delivery.

@nl

prefLabel

Synchronized and controlled re ...... m elementary osmotic delivery.

@en

Synchronized and controlled re ...... m elementary osmotic delivery.

@nl

P1476

Synchronized and controlled re ...... m elementary osmotic delivery.

@en

P2093

Hao Pan

http://www.w3.org/2001/XMLSchema#string

Hengpan Jing

http://www.w3.org/2001/XMLSchema#string

Tianbao Chen

http://www.w3.org/2001/XMLSchema#string

Weisan Pan

http://www.w3.org/2001/XMLSchema#string

Xinggang Yang

http://www.w3.org/2001/XMLSchema#string

P2860

Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance

Osmotically controlled drug delivery system with associated drugs

Oral osmotically driven systems: 30 years of development and clinical use

Clinical spectrum of the osmotic-controlled release oral delivery system (OROS), an advanced oral delivery form

Lifestyle change in Kerala, India: needs assessment and planning for a community-based diabetes prevention trial.

Investigations of a novel self-emulsifying osmotic pump tablet containing carvedilol.

Formulation aspects in the development of osmotically controlled oral drug delivery systems.

Fixed-dose combinations improve medication compliance: a meta-analysis.

Increased incidence of non-Hodgkin lymphoma, leukemia, and myeloma in patients with diabetes mellitus type 2: a meta-analysis of observational studies.

Impact of compliance with oral antihyperglycemic agents on health outcomes in type 2 diabetes mellitus: a focus on frequency of administration.

P304

780-788

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1080/03639045.2016.1200071

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2016-06-09T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27278057

http://www.w3.org/2001/XMLSchema#string

P921

metformin